Ultrasound active nanoscaled lipid formulations for thrombus lysis

作者：Becker Andreas^*; Marxer Elena; Bruessler Jana; Hoormann Anne Sophia; Kuhnt Daniela; Bakowsky Udo; Nimsky Christopher

来源：European Journal of Pharmaceutics and Biopharmaceutics, 2011, 77(3): 424-429.

DOI：10.1016/j.ejpb.2010.12.003

• Ultrasonography
• Nanomedicine
• Thrombolysis
• Contrast agent
• Microbubbles

In the present study, we investigated the sonothrombolytic effect of new nanoscaled lipid formulations in human blood clots, using diagnostic ultrasound. Human blood clots of 1 ml were incubated with 1 mu l of the different lipid dispersions DPPC/CH, DPPC/PEG40S, DSPC/PEG40S and the commercially available ultrasound contrast agent SonoVue (R). Clots were stored for 3 days at 5 degrees C to obtain maximal clot retraction and lytic resistance. Each clot weight was determined before and after continuous insonation for 1 h of insonation at 1.4 MHz. The pressure in the insonation chamber was 80 mm Hg to mimic middle arterial blood pressure. There were no significant differences in thrombus weight before insonation. All nanoscaled formulations and SonoVue (R) were able to reduce thrombus weight compared to the weight loss of clots that were not insonated but kept under pressure for one hour (p < 0.001). We found a highly significant weight reduction with DSPC/PEG40S compared to SonoVue (R) (p = 0.007).
Nanoscaled DSPC/PEG40S dispersion could be a promising formulation in ultrasound enhanced thrombolysis even without thrombolytic drugs. Stable cavitation is a crucial parameter in fragmentation of thrombus architecture. Further studies of physicochemical properties of DSPC/PEG40S are necessary to corroborate our hypothesis.

• 出版日期2011-4